Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Simon Garinet

7PUBLICATIONS

12CO-AUTHORS

Molecular targetsPredictive and prognostic markersCancer genetics

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Sep 04, 2025

Targeting <i>EGFR</i> Fusion in Metastatic Colorectal Cancer: A Case Report of a Lazarus Response in a 19-Year-Old Patient.

Annalice Gandini, Hélène Blons, Pierre Laurent-Puig

|May 15, 2023

A novel Chr1-miR-200 driven whole transcriptome signature shapes tumor immune microenvironment and predicts relapse in early-stage lung adenocarcinoma.

Simon Garinet, Audrey Didelot, Laetitia Marisa

|Jun 25, 2022

Discovery and validation of a transcriptional signature identifying homologous recombination-deficient breast, endometrial and ovarian cancers.

Guillaume Beinse, Pierre-Alexandre Just, Marie-Aude Le Frere Belda

|Mar 25, 2022

Updated Prognostic Factors in Localized NSCLC.

Simon Garinet, Pascal Wang, Audrey Mansuet-Lupo

|Nov 27, 2021

Next-Generation Sequencing Targeted Panel in Routine Care for Metastatic Colon Cancers.

Arnaud Bayle, Debora Basile, Simon Garinet

|Oct 13, 2021

Clinical assessment of the miR-34, miR-200, ZEB1 and SNAIL EMT regulation hub underlines the differential prognostic value of EMT miRs to drive mesenchymal transition and prognosis in resected NSCLC.

Simon Garinet, Audrey Didelot, Thomas Denize

Pageof 2

Frequent Collaborators

3 joint publications

Julien Taieb

2 joint publications

Pierre Laurent-Puig

1 joint publications

Thomas Denize

1 joint publications

Geraldine Perkins

1 joint publications

Pascal Wang

1 joint publications

Karen Leroy

1 joint publications

Valerie Taly

1 joint publications

Jérôme Alexandre

1 joint publications

Annalice Gandini

1 joint publications

Hélène Blons

Frequent Collaborators

3 joint publications

Julien Taieb

2 joint publications

Pierre Laurent-Puig

1 joint publications

Thomas Denize

1 joint publications

Geraldine Perkins

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening

Published on : Oct 26, 2017

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

See more related videos

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening

Published on : Oct 26, 2017

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

See more related videos